Insulet Corporation 019 Manuale Utente

•

Because insulin Pods use only rapid-acting insulin, users are 
at increased risk for developing hyperglycemia (high blood 
glucose) if insulin delivery is interrupted. If it is untreated, 
severe hyperglycemia can quickly lead to diabetic ketoacido-
sis (DKA). DKA can cause symptoms such as breathing difficul-
ties, shock, coma, or death. If insulin delivery is interrupted for 
any reason, you may need to replace the missing insulin usu-
ally with an injection of rapid-acting insulin. Ask your health-
care provider for instructions on handling interrupted insulin 
delivery.

Gather the following before you begin:
•

A vial of rapid-acting U-100 insulin (See the warning on 
page 8 of the Introduction for a list of insulins approved for 
use in the mylife OmniPod System.)

•

An unopened Pod

•

An alcohol prep swab

1. On the Home screen, use the Up/Down Controller buttons 

to choose More actions, then press Select.

2. Choose Change Pod (Figure 5-1), then press Select.
3. Press Confirm (Figure 5-2) to deactivate the current Pod.

NEVER use insulin that is cloudy; it may be old or inac-
tive. Failure to use rapid-acting U-100 insulin, or using 
insulin that is expired or inactive, may lead to hyper-
glycemia or diabetic ketoacidosis (DKA).

If you are a first-time mylife OmniPod System user, 
your healthcare provider will guide you through the 
steps for initializing and applying your first Pod. Do 
NOT attempt to apply or use a Pod until you have 
been trained by your healthcare provider. Use of the 
System with inadequate training or improper setup 
could put your health and safety at risk.